LZLyudmila A. Zimina

Lyudmila A. Zimina

*This is an algorithmically generated author record based on publicly available information.

Lyudmila A. Zimina has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Treatment of hyperammoniemia after orthotopic bilateral lung transplantation

    by V. A. Porkhanov, V. A. Zhikharev, I. S. Polyakov, V. F. Larin, V. A. Koriachkin, L. A. Zimina

    Background. Hyperammonemia is a rare but potentially life-threatening condition that can occur in patients following lung transplantation. Elevated blood ammonia levels are associated with impaired nitrogen metabolism leading to severe neurological symptoms, including confusion, seizures, and coma. Given the growing number of lung transplants, the problem of hyperammonemia is particularly important, as timely diagnosis and treatment can significantly reduce the risk of mortality. Objective. To present a case of acute hyperammonemia in a patient after bilateral lung transplantation, describing the treatment and successful outcome. Material and methods. A 58-year-old lung transplant recipient with chronic obstructive pulmonary disease (GOLD IV, extremely severe course, with pronounced clinical symptoms (mMRС>3, CAT test more than 10 points), emphysematous phenotype, high risk of exacerbations, class E, severe exacerbation). The clinical case description was based on the results of general clinical and instrumental studies from the recipient's medical history and observation card. Results. This article describes a clinical presentation of hyperazotemia and hyperammonemia, its successful treatment in a recipient following bilateral lung transplantation. By selecting an optimal treatment strategy, an adverse outcome was avoided and graft function was preserved. Conclusion. Although the pathophysiological mechanism for elevated blood urea levels and hyperammonemia could not be determined, a multimodal treatment approach enabled the clinicians to select the best management strategy for this patient and achieve a favorable outcome.

  • Open Access

    Clinical Evaluation of Analgesic Efficacy of Intrathecal Morphine in Thoracic Surgery

    by Vasiliy A. Zhikharev, Alexander S. Bushuev, Lyudmila A. Zimina, Robert A. Arutyunyan, Victor A. Koriachkin, Корячкин Виктор Анатольевич

    BACKGROUND: In thoracic surgery, pain intensity resulting from nociceptive stimulation due to skin incision, muscle trauma, rib retraction, and pleural dissection contributes to central sensitization and the development of severe postoperative pain, particularly in the early postoperative period. Intrathecal administration of morphine represents an alternative opioid-sparing component of multimodal acute pain management. AIM: The work aimed to clinically evaluate the analgesic efficacy of intrathecal morphine in patients undergoing thoracic surgery. METHODS: The study included 255 patients who underwent thoracoscopic lobectomy. Patients were allocated into three groups: group 1 (n = 85) received intrathecal morphine; group 2 (n = 85) received systemic opioid analgesics; and group 3 (n = 85) received intercostal nerve blockade with ropivacaine. Pain intensity was assessed 2 and 24 hours postoperatively, along with the need for rescue analgesia (trimeperidine or tramadol) and the incidence of postoperative nausea and vomiting, pruritus, urinary retention requiring bladder catheterization, and delayed respiratory depression. RESULTS: Two hours after surgery, pain intensity was lowest in the intercostal nerve block group (4 [3–4] cm on the visual analog scale [VAS]) and slightly higher in the intrathecal morphine group (4 [4–5] cm on the VAS). Both groups demonstrated a significantly greater analgesic effect compared with the systemic opioid analgesia group (6 [5–6] cm on the VAS; p 0.001). At 24 hours postoperatively, pain intensity in group 1 decreased to 3 [2–3] cm on the VAS, whereas in group 2 it increased to 6 [5–6] cm, comparable with group 3 (6 [5–6] cm; p 0.001). Trimeperidine consumption was significantly lower in group 1 (p 0.001). The frequency of tramadol administration was also reduced (p 0.001). The highest incidence of postoperative nausea and vomiting was observed in group 2 (p 0.001). The incidence of pruritus and urinary retention did not differ significantly among groups. No cases of delayed respiratory depression were reported. CONCLUSION: Intrathecal administration of morphine significantly reduced pain intensity, decreased the need for opioid analgesics, and was associated with a low incidence of pruritus within the first 24 hours after surgery. The incidence of postoperative nausea and vomiting was lower compared with both systemic opioid analgesia and intercostal nerve block. The need for urinary catheterization did not differ among groups. No delayed respiratory depression was observed.


  • Open Access

    Perfusion index as an early predictor of hypotension during advanced oncothoracic operations (pilot study)

    by L. A. Zimina, A. S. Bushuev, R. A. Arutyunyan, V. А. Zhikharev

    Introduction. Current standards of intraoperative monitoring significantly reduce the response time to a decrease in blood pressure, but do not include methods for predicting changes in hemodynamics to avoid the effects of systemic hypoperfusion.The objective was to evaluate the usefulness of determining the perfusion index for predicting the development of hypotension and its earlier correction during advanced oncothoracic operations.Materials and methods. A prospective open-label observational study was conducted, which included 100 patients who underwent elective oncothoracic surgery. Standard monitoring was established, as well as continuous monitoring of the perfusion index. The perfusion index value was recorded immediately before induction. The patients were divided into 2 groups: in the 1st group (n = 37), patients experienced a decrease in blood pressure, requiring vasopressor support; in the 2nd group (n = 63), no vasopressor support was required.Results. A moderate linear relationship was revealed with a correlation coefficient (r) equal to (–0.68), p < 0.001, and a strong non-linear relationship with a coefficient (ρ) equal to (–0.95), p < 0.001. To identify the relationship model, polynomial regression analysis was performed. A prognostic formula for the use of vasopressors was calculated depending on the preoperative level of perfusion index. At the next stage, a classification tree for analyzing the data array was used. The entire d data array (n = 100) is randomly divided into training (n = 70) and test samples (n = 30). It was revealed that hypotension requiring vasopressor support occurred in patients whose initial perfusion index was ≤ 2.85. ROC analysis determined an AUC of 0.952 (95% CI: 0.888–1.016).Conclusion. A low PI value before induction of anesthesia during advanced oncothoracic operations can be used to monitor the functional activity of the autonomic nervous system and predict intraoperative hypotension. Patients with a baseline PI ≤ 2.85 have a higher risk of developing hypotension during advanced oncothoracic surgery compared with those with a baseline PI ≥ 2.85. The effectiveness of the method in patients with concomitant pathologies has not been tested.


  • Open Access

    The effect of opioid-free anesthesia using lidocaine on the level of inflammatory markers in thoracic patients in the intra- and postoperative period: prospective randomized study

    by Vasily A. Zhikharev, Alexander S. Bushuev, Lyudmila A. Zimina, Robert A. Arutyunyan, Viktor A. Koriachkin, Жихарев Василий Александрович

    BACKGROUND: A pressing issue still remains the reduction of opioid analgesic dosages as a part of anesthesiological support, due to the wide range of complications they cause. An alternative to opioids is opioid-free anesthesia, including the use of lidocaine, which can influence the activity of cytokines, which reflects the advisability of its use in order to prevent an increase in the content of inflammatory markers in the postoperative period. In the domestic and foreign scientific literature, the issue of the dependence of the level of inflammatory markers on the use of non-opioid anesthesia in comparison with opioid anesthesia is relatively little studied, especially in the field of thoracic surgery. AIM: Our aim was to conduct a comparative analysis of the content of cytokines as markers of inflammation during anesthesia using intravenous lidocaine infusion, intravenous fentanyl infusion and a combination of intravenous fentanyl and epidural anesthesia. MATERIALS AND METHODS: A single-center, prospective, randomized study was conducted among 90 patients with a verified diagnosis of lung cancer who underwent video-assisted thoracoscopic (Vlobectomy. Depending on the method of anesthesia, patients were divided into 3 groups of 30 people: in the 1st group, lidocaine was administered, in the 2nd group, fentanyl was administered, and in the 3rd group, fentanyl was administered in combination with epidural anesthesia. The main result of the study was the assessment of the concentration of cytokines in the blood serum (interleukins - IL-2, IL-6, IL-10, as well as tumor necrosis factor α — TNF-α) using an enzyme-linked immunosorbent assay. An additional outcome was a laboratory assessment of the concentrations of glucose and cortisol in the blood serum (the analysis of these indicators was performed to assess the adequacy of anesthetic management in the intraoperative period). Statistical analysis of the results was carried out using the Python v.3.0 programming language in Jupiter Notebook. RESULTS: Analysis of IL-6 content showed a significant difference in favor of group 1 already at the end of the operation (H=10.366691, p=0.0056); 1 day after the end of the operation, the difference in the indicator between the groups increased (H=65.603614 , p 0.001) with the lowest value in group 1. The level of TNF-α at the end of the operation did not reflect significant differences between the groups (H=0.578241, p=0.748922), however, after 24 hours, changes made it possible to note positive dynamics also in group 1 (H=12.928289 , p=0.001558). Similar results were recorded for IL-10 [(H=1.325812, p=0.515352) and (H=9.11072, p=0.010511)] and IL-2 [(H=5.185739, p=0.074805) and (H=23.420171, p=0.000008)], respectively. CONCLUSION: Our results showed that opioid-free anesthesia based on intravenous lidocaine infusion positively correlates with serum concentrations of IL-2, IL-6, IL-10, and TNF-α in patients undergoing thoracic surgery. Serum levels of these cytokines may be indicators of inflammatory responses and may have clinical implications for selecting appropriate anesthesia for patients with lung cancer. In addition, data regarding IL-2 are new and may be associated with tumor progression and the occurrence of distant metastases.


  • Open Access

    Intravenous infusion of lidocaine as a component of opioid-free anesthesia in thoracic surgery: prospective randomized single-center observational study

    by Lyudmila A. Zimina, Vasiliy A. Zhikharev, Alexander S. Bushuev, Viktor A. Koriachkin, Yuri P. Malyshev

    BACKGROUND: The possibility of reducing doses of narcotic analgesics during the perioperative period is widely discussed in modern scientific literature. This direction is called opioid-free anesthesia and is used in abdominal surgery, oncology, gynecology, and other areas. Publications on the use of opioid-free anesthesia in thoracic surgery are scarce. OBJECTIVE: To evaluate the analgesic effectiveness of intravenous lidocaine infusion as a component of anesthesia in thoracic surgery. MATERIALS AND METHODS: Ninety patients who underwent open lobectomy or pneumonectomy were examined. Depending on the analgesic component, patients were divided into three groups: group 1 (n=30) received intravenous infusion of lidocaine, group 2 (n=30) received epidural block, and group 3 (n=30) had fentanyl infusion. Blood pressure, heart rate, cortisol, and blood serum glycemia levels were measured. The intensity of postoperative pain syndrome and the need for promedol, tramadol, and sanitation fibrobronchoscopy were assessed. Arterial hypotension and frequency of postoperative nausea and vomiting were recorded. The length of stay of the patients in the intensive care unit and hospital was recorded. RESULTS: Cortisol levels did not differ between groups (p=0.26). The glucose level in the epidural block group was significantly lower than that in other groups (p=0.011). A significant increase in mean blood pressure and heart rate was observed in the opioid analgesia group (p 0.001). The lowest severity of pain 6 h after surgery was observed in the epidural blockade and lidocaine groups (p 0.001). Perioperative hypotension was more common in the epidural analgesia group (p=0.045). The incidence of postoperative nausea and vomiting was higher in the opioid anesthesia group (p=0.004). In the fentanyl infusion group, sanitary fibrobronchoscopy was more often required to eliminate atelectasis (p=0.039). The number of bed days spent in the ICU was significantly higher in the opioid analgesic group (p=0.002); however, no significant differences were noted between the groups regarding the number of days spent in the hospital (p=0.228). CONCLUSION: Opioid-free anesthesia based on intravenous lidocaine infusion, as a component of anesthetic management in thoracic surgery, provides sufficient perioperative stability of hemodynamic and neuroendocrine status, has a pronounced analgesic effect, with less opioid consumption on the first day after surgery, and helps reduce the length of stay in the intensive care unit and hospital.